市場調查報告書

鼻腔給藥系統的全球市場 - 市場預測 ∼2026年

Nasal Drug Delivery Systems Market - Global Forecast to 2026

出版商 Coherent Market Insights 商品編碼 785765
出版日期 內容資訊 英文 180 Pages
商品交期: 2-3個工作天內
價格
鼻腔給藥系統的全球市場 - 市場預測 ∼2026年 Nasal Drug Delivery Systems Market - Global Forecast to 2026
出版日期: 2018年07月13日內容資訊: 英文 180 Pages
簡介

鼻腔給藥可避免肝臟的首過效應,最重要的是對患者的負擔低,成為在藥物輸送中最有前途的給藥途徑之一。

本報告提供全球鼻腔給藥系統市場調查,市場概要,各劑型、容器類型、系統類型、治療領域、終端用戶、地區的市場規模的變化與預測,市場成長要素及阻礙因素分析,市場機會,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 調查目的與前提條件

  • 調查目的
  • 前提條件
  • 簡稱

第2章 市場概要

  • 報告的說明
  • 市場定義和範圍
  • 摘要整理
    • 市場片段:各劑型
    • 市場片段:各容器類型
    • 市場片段:各系統類型
    • 市場片段:各治療領域
    • 市場片段:各流通管道
    • 市場片段:各地區
  • Coherent Opportunity Map(COM)

第3章 市場動態,法規,趨勢分析

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 產業趨勢
  • 最近的認證
  • 法規方案
  • 流行病學
  • PEST分析

第4章 鼻腔給藥系統市場:各劑型

  • 簡介
  • 經鼻噴霧
  • 滴鼻劑
  • 經鼻凝膠
  • 經鼻粉
  • 其他

第5章 鼻腔給藥系統市場:各容器類型

  • 簡介
  • 非加壓容器
  • 加壓容器

第6章 鼻腔給藥系統市場:各系統類型

  • 簡介
  • 多回給藥
  • 二次給藥
  • 單位劑量給藥

第7章 鼻腔給藥系統市場:各治療領域

  • 簡介
  • 過敏性/非過敏性鼻炎
  • 鼻塞
  • 疫苗接種
  • 其他

第8章 鼻腔給藥系統市場:各終端用戶

  • 簡介
  • 醫院藥局
  • 零售藥局
  • 線上藥局

第9章 鼻腔給藥系統市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • ASEAN
    • 澳洲
    • 韓國
    • 其他
  • 南美
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他
  • 中東
    • 波灣合作理事會(CGG)
    • 以色列
    • 其他
  • 非洲
    • 北非
    • 中非
    • 南非

第10章 競爭環境

  • 熱圖分析
  • 企業簡介
    • Merck & Co.
    • GlaxoSmithKline plc
    • AstraZeneca plc
    • Johnson & Johnson
    • Pfizer Inc.
    • Baxter International, Inc.
    • Valeant Pharmaceuticals International, Inc.
    • Becton, Dickinson and Company
    • Novartis AG

第11章 分析師觀點

第12章 Section

  • 參考文獻
  • 調查方法
  • 關於Coherent Market Insights
目錄

Nasal cavity is becoming one of the most potential and promising route of drug delivery, owing to its advantages such as bypassing the hepatic first-pass metabolism, and most importantly patient convenience. The report provides in depth understanding of developing intranasal formulation to achieve better therapeutic objective, in turn drive the market share. However, the report also focuses on the practical and technical factors which remains the hindrance for the global nasal drug delivery system market growth over the forecast period. Furthermore, report tracks and forecast the market growth of each segment for the period of 2016-2026.

Market Dynamics

The major factors driving growth of the nasal drug delivery systems market includes, increasing product launches coupled with technologically advanced drug delivery systems and increasing incidence of nasal cavity associated diseases. For instance, in June 2018, Insys Therapeutics, Inc., a specialty pharmaceutical company, conducted clinical trial for epinephrine nasal spray, an alternative for intramuscular injection for the indication of anaphylaxis. Furthermore, companies have large number of pipeline drugs, which are to be delivered intranasally such as Acerus Pharmaceuticals Corporation is investigating TEFINA, a testosterone nasal gel, for addressing the unmet treatment demand for female sexual dysfunction. However, intranasal route of drug delivery is not suitable for all drug types, which is expected to be a major restrain for growth of the nasal drug delivery systems market.

Key features of the study:

This report provides in-depth analysis of the nasal drug delivery systems market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global nasal drug delivery systems market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans

Key companies covered as a part of this study include Merck & Co., GlaxoSmithKline plc, AstraZeneca plc, Johnson & Johnson, Pfizer Inc., Baxter International, Inc., Valeant Pharmaceuticals International, Inc., Becton, Dickinson and Company and Novartis AG

Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, distribution channel upgrades, market expansion and marketing tactics.

The global nasal drug delivery systems market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers of nasal drug delivery system, research and consulting firms, new entrants, and financial analysts

Various strategy matrices used in analyzing the nasal drug delivery systems market would provide stakeholders vital inputs to make strategic decisions accordingly

Detailed Segmentation:

  • Global Nasal Drug Delivery Systems Market, By Dosage Form:
  • Nasal Spray
  • Nasal Drops
  • Nasal Gels
  • Nasal Powders
  • Others
  • Global Nasal Drug Delivery Systems Market, By Container Type:
  • Non-pressurized Containers
  • Pressurized Containers
  • Global Nasal Drug Delivery Systems Market, By System Type:
  • Multi-dose
  • Bi-dose
  • Unit Dose
  • Global Nasal Drug Delivery Systems Market, By Therapeutic Application:
  • Allergic and Non-allergic Rhinitis
  • Nasal Congestion
  • Vaccination
  • Others
  • Global Nasal Drug Delivery Systems Market, By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Global Nasal Drug Delivery Systems Market, By Region:
  • North America
  • By Dosage Form:
  • Nasal Spray
  • Nasal Drops
  • Nasal Gels
  • Nasal Powders
  • Others
  • By Container Type:
  • Non-pressurized Containers
  • Pressurized Containers
  • By System Type:
  • Multi-dose
  • Bi-dose
  • Unit Dose
  • By Therapeutic Application :
  • Allergic and Non-allergic Rhinitis
  • Nasal Congestion
  • Vaccination
  • Others
  • By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • U.S.
  • Canada
  • Latin America
  • By Dosage Form:
  • Nasal Spray
  • Nasal Drops
  • Nasal Gels
  • Nasal Powders
  • Others
  • By Container Type:
  • Non-pressurized Containers
  • Pressurized Containers
  • By System Type:
  • Multi-dose
  • Bi-dose
  • Unit Dose
  • By Therapeutic Application :
  • Allergic and Non-allergic Rhinitis
  • Nasal Congestion
  • Vaccination
  • Others
  • By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Dosage Form:
  • Nasal Spray
  • Nasal Drops
  • Nasal Gels
  • Nasal Powders
  • Others
  • By Container Type:
  • Non-pressurized Containers
  • Pressurized Containers
  • By System Type:
  • Multi-dose
  • Bi-dose
  • Unit Dose
  • By Therapeutic Application :
  • Allergic and Non-allergic Rhinitis
  • Nasal Congestion
  • Vaccination
  • Others
  • By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • Germany
  • U.K.
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Dosage Form:
  • Nasal Spray
  • Nasal Drops
  • Nasal Gels
  • Nasal Powders
  • Others
  • By Container Type:
  • Non-pressurized Containers
  • Pressurized Containers
  • By System Type:
  • Multi-dose
  • Bi-dose
  • Unit Dose
  • By Therapeutic Application :
  • Allergic and Non-allergic Rhinitis
  • Nasal Congestion
  • Vaccination
  • Others
  • By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
  • By Dosage Form:
  • Nasal Spray
  • Nasal Drops
  • Nasal Gels
  • Nasal Powders
  • Others
  • By Container Type:
  • Non-pressurized Containers
  • Pressurized Containers
  • By System Type:
  • Multi-dose
  • Bi-dose
  • Unit Dose
  • By Therapeutic Application :
  • Allergic and Non-allergic Rhinitis
  • Nasal Congestion
  • Vaccination
  • Others
  • By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Dosage Form:
  • Nasal Spray
  • Nasal Drops
  • Nasal Gels
  • Nasal Powders
  • Others
  • By Container Type:
  • Non-pressurized Containers
  • Pressurized Containers
  • By System Type:
  • Multi-dose
  • Bi-dose
  • Unit Dose
  • By Therapeutic Application :
  • Allergic and Non-allergic Rhinitis
  • Nasal Congestion
  • Vaccination
  • Others
  • By Distribution Channel:
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • By Country:
  • North Africa
  • Central Africa
  • South Africa
  • Company Profiles
  • Merck & Co.*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Market Strategies
  • GlaxoSmithKline plc
  • AstraZeneca plc
  • Johnson & Johnson
  • Pfizer Inc.
  • Baxter International, Inc.
  • Valeant Pharmaceuticals International, Inc.
  • Becton, Dickinson and Company
  • Novartis AG
  • “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
  • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Dosage Form
    • Market Snippet, By Container Type
    • Market Snippet, By System Type
    • Market Snippet, By Therapeutic Application
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Industry Trends
  • Recent Approvals
  • Regulatory Scenario
  • Epidemiology
  • PEST Analysis

4. Global Nasal Drug Delivery Systems Market, By Dosage Form, 2016 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Nasal Spray
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Nasal Drops
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Nasal Gels
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Nasal Powders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

5. Global Nasal Drug Delivery Systems Market, By Container Type, 2016-2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Non-Pressurized Containers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Pressurized Containers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

6. Global Nasal Drug Delivery Systems Market, By System Type, 2016-2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Multi Dose
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Bi-Dose
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Unit Dose
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

7. Global Nasal Drug Delivery Systems Market, By Therapeutic Application, 2016-2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Allergic and Non-Allergic Rhinitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Nasal Congestion
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Vaccination
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

8. Global Nasal Drug Delivery Systems Market, By Distribution Channel, 2016-2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Hospitals Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

9. Global Nasal Drug Delivery Systems Market, By Regions, 2016-2026, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, By Region, 2017 - 2026
    • Regional Trends
  • North America
    • Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Container Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By System Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Therapeutic Application, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • U.S.
  • Canada
  • Europe
    • Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Container Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By System Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Therapeutic Application, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Container Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By System Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Therapeutic Application, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Container Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By System Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Therapeutic Application, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Container Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By System Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Therapeutic Application, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Dosage Form, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Container Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By System Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Therapeutic Application, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
  • Northern Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Merck & Co.*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Market Strategies
    • GlaxoSmithKline plc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Market Strategies
    • AstraZeneca plc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Market Strategies
    • Johnson & Johnson
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Market Strategies
    • Pfizer Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Market Strategies
    • Baxter International, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Market Strategies
    • Valeant Pharmaceuticals International, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Market Strategies
    • Becton, Dickinson and Company
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Market Strategies
    • Novartis AG
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Market Strategies

11. Analyst Views

12. Section

  • References
  • Research Methodology
  • About Us and Sales Contact